Mereo BioPharma (MREO) Operating Leases (2018 - 2024)
Mereo BioPharma (MREO) posted quarterly Operating Leases of $187000.0 for Q4 2024, down 79.36% year-on-year from $906000.0 in Q1 2024, and down 52.54% on a QoQ basis from $394000.0 in Q3 2024.
Mereo BioPharma (MREO) Operating Leases (2018 - 2024) Analysis & Trends
Mereo BioPharma (MREO) has reported Operating Leases for 7 consecutive years, with $187000.0 the latest figure, recorded in Q4 2024.
- Quarterly Operating Leases fell 79.36% year-over-year to $187000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $187000.0 (down 79.36% YoY) and the FY2024 annual result came in at $187000.0, down 79.36% from the prior year.
- Operating Leases fell to $187000.0 in Q4 2024 per MREO's latest filing, from $394000.0 in the prior quarter.
- Over the last five years, Operating Leases for MREO reached as high as $13.9 million in Q2 2020 and fell as low as $187000.0 in Q4 2024.
- A 5-year average of $2.4 million and a median of $1.4 million in 2022 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2020 — Operating Leases plunged 87.24% — and 2021, when it surged 54.63%.
- Year by year, Operating Leases stood at $1.5 million in 2020, then jumped by 54.63% to $2.4 million in 2021, then slumped by 39.38% to $1.4 million in 2022, then plunged by 36.79% to $906000.0 in 2023, then plunged by 79.36% to $187000.0 in 2024.
- According to Business Quant data, Operating Leases over the past three periods registered $187000.0, $394000.0, and $552000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mereo BioPharma | 232.52 Mn | 232.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 187,000.00 |
| Sep 30, 2024 | 394,000.00 |
| Jun 30, 2024 | 552,000.00 |
| Mar 31, 2024 | 1.39 Mn |
| Dec 31, 2023 | 906,000.00 |
| Jun 30, 2023 | 1.22 Mn |
| Dec 31, 2022 | 1.43 Mn |
| Jun 30, 2022 | 1.83 Mn |
| Dec 31, 2021 | 2.36 Mn |
| Jun 30, 2021 | 2.73 Mn |
| Dec 31, 2020 | 1.53 Mn |
| Jun 30, 2020 | 13.87 Mn |
| Dec 31, 2019 | 11.98 Mn |
| Jun 30, 2019 | 16.90 Mn |
| Dec 31, 2018 | 3.26 Mn |